title: Current approaches to skin cancer management in organ transplant recipients.
abstract: Approximately 225,000 people are living with organ transplants in the United States. Organ transplant recipients have a greater risk of developing skin cancer, including basal cell carcinoma, squamous cell carcinoma, and malignant melanoma, with an approximately 250 times greater incidence of squamous cell carcinoma in certain transplant recipients, compared with the general population. Because skin cancers are the most common posttransplant malignancy, the resultant morbidity and mortality in these high-risk patients is quite significant.
authors.affiliation: Mayo School of Graduate Medical Education, College of Medicine, Mayo Clinic, Rochester, MN, USA.
authors.forename: Meena K
authors.initials: MK
authors.lastname: Singh
authors.forename: Jerry D
authors.initials: JD
authors.lastname: Brewer
mesh_terms: D002280:Basal Cell Carcinoma / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D006801:Humans; D016867:Immunocompromised Host; D008545:Melanoma / Q000628:therapy*; D012307:Risk Factors; D012878:Skin Neoplasms / Q000628:therapy*; D014181:Transplantation Immunology